查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1576965

多模態成像的全球市場的評估:各技術，各用途，各終端用戶，各地區，機會，預測(2017年～2031年)

Multimodal Imaging Market Assessment, By Technology, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 238 Pages | 商品交期: 3-5個工作天內

價格

全球多模態影像市場規模預計將從 2023 年的 45.2 億美元增至 2031 年的 70.9 億美元，在 2024-2031 年預測期內複合年增長率為 5.79%。由於慢性病的增加、企業投資、對精確診斷的需求不斷增加、政府舉措的增加、醫學成像技術的進步以及多模態成像系統的日益採用，該市場正在增長並將繼續以同樣的速度增長。預測。

多模態成像是一種將多種成像技術集成為一體的系統，可提供更詳細、更準確的診斷視圖。將多種模式集成為一種模式可以增強傳統成像技術，並實現複雜生物結構和過程的詳細可視化。這使得診斷更加準確並提高醫學影像的整體品質。

在現代醫學中，多模態影像透過提供對生物結構及其功能的深入了解而發揮重要作用。多模態成像市場的主要驅動力是由於全球人口老化、政府升級醫療保健系統的舉措以及支持性報銷政策的改善，對一般醫療診斷的即時成像解決方案的需求不斷增長。此外，便攜式多模態成像技術正在不斷改進，推動了門診和緊急服務的需求，並促使了新的具有成本效益的行動系統的開發。例如，2023 年 1 月，Cobalt Health 利用西門子 Healthineers 先進的 PET/CT 技術推出了行動 PET/CT 服務。此移動系統配備齊全，設有接待處、等候區、檢查室、四個住院室以及患者和工作人員所需的其他設施。該產品的推出強烈表明，對行動多模態成像解決方案的需求不斷增長，以改善不同環境下醫療保健服務的可及性和便利性。

此外，公司正在投資擴大其在世界各地的設施，以方便獲得先進的醫療解決方案，這正在推動多模態成像市場的成長。例如，2024 年 3 月，Wipro GE Healthcare Pvt. Ltd 宣布投資 96 億美元用於本地製造和研發。由此，該公司打算將 PET CT、CT 和 MR 線圈的製造在印度本地化，並提高印度在醫療技術領域的全球重要性。這項投資增強了當地的製造能力，以滿足不斷增長的國內和全球醫療需求，並反映了對行動多模態成像解決方案不斷增長的需求。

本報告提供全球多模態成像市場相關調查分析，提供市場規模與預測，市場動態，主要企業的形勢等資訊。

目錄

第1章 計劃的範圍和定義

第2章 調查手法

第3章 摘要整理

第4章 全球多模態成像市場預測(2017年～2031年)

  • 市場規模的分析與預測
    • 金額
    • 數量
  • 市場佔有率的分析與預測
    • 各技術
    • 各用途
    • 各終端用戶
    • 各地區
    • 市場佔有率分析:各企業(金額)(前五名公司和其他 - 2023年)
  • 市場地圖分析(2023年)
    • 各技術
    • 各用途
    • 各終端用戶
    • 各地區

第5章 北美的多模態成像市場預測(2017年～2031年)

  • 市場規模的分析與預測
    • 金額
    • 數量
  • 市場佔有率的分析與預測
    • 各技術
    • 各用途
    • 各終端用戶
    • 佔有率:各國
  • 各國的市場評估
    • 美國的多模態成像市場預測(2017年～2031年)
    • 加拿大
    • 墨西哥

第6章 歐洲的多模態成像市場預測(2017年～2031年)

  • 德國
  • 法國
  • 義大利
  • 英國
  • 俄羅斯
  • 荷蘭
  • 西班牙
  • 土耳其
  • 波蘭

第7章 亞太地區的多模態成像市場預測(2017年～2031年)

  • 印度
  • 中國
  • 日本
  • 澳洲
  • 越南
  • 韓國
  • 印尼
  • 菲律賓

第8章 南美的多模態成像市場預測(2017年～2031年)

  • 巴西
  • 阿根廷

第9章 中東·非洲的多模態成像市場預測(2017年～2031年)

  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章 價值鏈分析

第11章 波特的五力分析

第12章 大環境分析

第13章 價格分析

第14章 市場動態

  • 推動市場要素
  • 市場課題

第15章 市場趨勢與發展

第16章 法規結構和革新

  • 法規當局的認證

第17章 專利形勢

第18章 案例研究

第19章 競爭情形

  • 市場前五名領導者企業的競爭矩陣
  • 前五名公司的SWOT分析
  • 前十大主要企業的形勢
    • Siemens Healthineers AG
    • GE HealthCare
    • Koninklijke Philips N.V.
    • Canon Medical Systems Corporation
    • Shanghai United Imaging Healthcare Co., LTD
    • Neusoft Medical Systems Co., Ltd.
    • MinFound Medical Systems Co., Ltd
    • Spectrum Dynamics Medical
    • Mediso Ltd.
    • Bruker Corporation

第20章 策略性推薦

第21章 本公司相關資料，免責聲明

Product Code: MX12161

Global multimodal imaging market is projected to witness a CAGR of 5.79% during the forecast period 2024-2031, growing from USD 4.52 billion in 2023 to USD 7.09 billion in 2031. The market for multimodal imaging systems is rising due to increasing chronic diseases, corporate investments, rising demand for precision diagnosis, increasing government initiatives, technological advancements in medical imaging, and increased adoption of multimodal imaging systems, and it is expected that it will keep growing at the same pace.

Multimodal imaging is a system integrating various imaging techniques into one, hence providing a more detailed and accurate view for diagnosis. It enhances the traditional imaging methodology by combining multiple modalities into one, enabling the visualization of complex biological structures and processes in detail. This leads to more accurate diagnoses, generally improving the quality of medical imaging.

In modern healthcare, multimodal imaging plays a vital role by providing insights into biological structures and their functions. Some of the key factors driving the multimodal imaging market include increasing demand for point-of-care imaging solutions for general medical diagnosis due to an increasing aging population worldwide, and government initiatives toward upgrading healthcare systems and making technology more accessible with supportive reimbursement policies. Additionally, portable multimodal imaging technology is continuously improving, fueling its demand for ambulatory and emergency services and leading to the development of new, cost-effective mobile systems. For instance, in January 2023, Cobalt Health introduced a mobile PET/CT service using the advanced Siemens Healthineers PET/CT technology. This mobile is fully fitted with a reception area, waiting room, lab, four uptake rooms, and all other necessary facilities for both patients and staff, just like any full PET/CT department. Its launch can underline the growing demand for mobile and multimodality imaging solutions to enhance access and convenience for healthcare delivery across diverse settings.

Furthermore, companies are also investing in the expansion of their facilities across the globe to promote access to advanced healthcare solutions, thereby driving the growth of the multimodal imaging market. For instance, in March 2024, Wipro GE Healthcare Pvt. Ltd. presented a USD 9,600 million investment in local manufacturing and R&D. With this, the company intends to localize the manufacturing of PET CT, CT, and MR coils in India and increase the country's significance globally in the MedTech sector. This investment reflects the growing demand for mobile and multimodal imaging solutions on account of strengthening local production capabilities to meet ever-growing healthcare needs in the country and worldwide.

Rising Prevalence of Chronic Diseases

With the rising incidences of prostate cancer, Alzheimer's disease, and various neurological disorders, there is an increasing demand for advanced and reliable diagnostic imaging technologies along with effective treatments. As these diseases become more prevalent, there is a growing demand for advanced imaging solutions combining various modalities. Hybrid imaging technologies have the potential to play a significant role in disease diagnosis and treatment. These technologies combine various imaging techniques for more accurate and comprehensive insights necessary for dealing with these health issues. According to the World Health Organization (WHO), there were approximately 1.47 million cases of prostate cancer in 2022 worldwide, and the cases are projected to increase to 2.63 million by 2045. This increase demonstrates, most poignantly, the need for better diagnostic techniques to save more lives. Multimodal imaging integrates two or more imaging techniques into one, thereby overcoming the drawbacks of single-modality imaging with the complementary data it offers. This approach offers a more comprehensive view of the disease and its progression. This enables clinicians to establish a more precise tumor staging, which is essential for selecting appropriate treatments. Therefore, multimodal imaging has become an important tool in cancer management. So, if these health conditions continue to grow, the demand for multimodal imaging is expected to grow.

For instance, in June 2023, at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, GE HealthCare unveiled an updated PET/MR system with AIR Technologies. The new SIGNA PET/MR AIR system was highlighted to enhance diagnostic precision, accelerate treatment assessment, and make patients more comfortable. This technology could make giant leaps in the diagnosis and treatment of prostate cancer, probably revolutionizing future medical imaging and treatment approaches.

Technological Advancements in Medical Imaging Drives the Market Growth

Continuous technological advancements within the multimodal imaging system strongly drive the multimodal imaging market growth. Some of the major developments are higher resolution and sensitivity, which together increase the precision and detail of imaging. These technological improvements remarkably enhance diagnostic capabilities and treatment planning. In oncology, for example, such advanced imaging may allow for more accurate visualization of the tumor to thus help in proper localization and the delivery of therapy with precision. Such a level of detail not only helps diagnostic accuracy but also enhances treatment planning for improved patient outcomes. Companies are strategically working on the development of advanced imaging technologies. The integration of the latest developments has helped companies build functionality into their products by enhancing the ability to improve effectiveness.

For instance, in November 2023, The Biograph Vision.X PET/CT from Siemens Healthineers received FDA approval. This represents a significant advancement in multimodal imaging by Siemens Healthineers. Driven by its leading flight time of 178 picoseconds, it uses advanced Optiso Ultra Dynamic Range (UDR) detector technology with 3.2 mm x 3.2 mm high-resolution LSO crystal elements. Its AIDAN platform featuring FlowMotion AI eases operational efficiency to the next level and personalizes the acquisition process for individual patients with AI-driven precision. This improves image clarity significantly, with great help in detecting even the smallest lesions for diagnosis with great accuracy. As these technologies continue to evolve, they are allowing more comprehensive assessments and fostering greater adoption, thus accelerating the growth of the multimodal imaging market. The continuous advancement in medical imaging represents a dynamic and increasingly crucial area for modern diagnostics and therapies.

Dominance of Technology in the Multimodal Imaging Market

The technology segment has a major share in the global multimodal imaging market. Several factors influence market growth, including investment in multimodal imaging systems, the growing prevalence of chronic diseases, and the increasing demand for better turnaround times, high-resolution imaging, and greater precision. The new product launch, together with the widespread adoption of the technology, underscores the increasing demand for this technology in the market. With advances in technology, the development of even more advanced imaging systems continues to expand the capabilities for diagnosing and treating patients. The continued efforts to improve precision and effectiveness in imaging diagnostics demonstrate the market expansion.

For instance, in June 2024, Siemens Healthineers AG introduced the Biograph Trinion PET/CT scanner. The high-performance scanner is energy-efficient and cost-efficient. It offers a range of clinical capabilities at lower operational costs. Some of its features include scalable, air-cooled digital detectors with enhanced spatial resolution and ultra-fast time-of-flight performance that further enhances small lesion detectability and sensitivity. An integrated platform replaces separate systems to carry out seamless workflows for PET and CT, smoothing the process. Artificial Intelligence and intelligent user interfaces further enhance operational efficiency. Such launches and advancements underline the dominance of PET/CT and drive growth in the multimodal imaging market.

North America Accounts for the Largest Share of the Multimodal Imaging Market

North America is expected to lead the multimodal imaging market in North America, which is driven by high demand from the United States and Canada. Various factors, including a high prevalence of chronic diseases, an aging population, and a well-structured healthcare system with strong reimbursement policies, support this leadership. The advanced healthcare infrastructure in the region encourages the wide use of advanced imaging technologies. Additionally, key players and companies headquartered in North America also contribute to enhancing their imaging solutions. Initiatives taken by organizations like the US FDA towards creating awareness about health, along with frequent new product launches and approvals, are driving demand for multimodal imaging tools in the region. This blend of leading healthcare developments with active market participation represents the leading position of North America in the multimodal imaging market.

For instance, in July 2024, Positron Corporation, a molecular imaging company, introduced the NeuSight PET-CT 3D 64-slice scanner in the United States and North American markets, which is advanced yet economical. NeuSight is manufactured by Neusoft Medical Systems, but Positron Corporation will handle the sales of NeuSight in the region as per its agreement with Shenyang Intelligent Nuclear Medical Technology Co., a subsidiary of Neusoft Medical Systems. This advanced technology has attained milestones in cardiac PET imaging by delivering high-quality imaging and diagnostic accuracy while ensuring patient comfort and ease of operation. Such innovative, pioneering technologies being developed within the region contribute to North America's leading position in the multimodal imaging market.

Future Market Scenario (2024-2031F)

Portable multi-modality imaging systems are the future of imaging. For instance, in April 2024, CDL Nuclear Technologies launched the new Mobile Cardiac PET/CT Trailer. This mobile unit brings sophisticated cardiac PET/CT imaging capabilities directly onto the doorstep of medical facilities, greatly improving access to quality diagnostic services. These would be very helpful for those facilities that do not have advanced imaging on-site or have had very limited access to advanced technology. The Mobile Cardiac PET/CT Trailer presents a minimal financial and operational risk to any hospital trying to expand cardiovascular imaging services. A module that fits seamlessly into the existing healthcare infrastructure with full conformance to regulatory standards, this product also underlines the growing trend toward flexible, on-demand imaging services. These innovations will be the future of multimodal imaging, offering unparalleled access and speed in diagnosis.

Artificial intelligence will continue to transform multimodal imaging. AI-based algorithms are increasingly integrated into the systems to allow for a smoother workflow and increase diagnostic accuracy. For example, in May 2024, Blue Earth Diagnostics announced a data-sharing agreement with Siemens Healthineers to share anonymized clinical data from its Phase 3 LIGHTHOUSE trial with the Company's medical imaging arm. Siemens Healthineers will use all the gathered data to further refine its AI algorithms for imaging prostate cancer. A major point in using AI will be integrating the solutions of multimodal imaging, hence optimizing the process of analysis and preparing essential information for patient care, driving future growth in the market for multimodal imaging.

Key Players Landscape and Outlook

There has been a high level of activity in the market through mergers and collaborations to increase the market shares of the leading companies. Partnerships and acquisitions have been strategic in developing capabilities, product portfolios, and market reach. This allows key players to fully utilize combined expertise and resources to drive growth and innovation within the sector. New product launches, regulatory approvals, and collaboration with hospitals are key strategies that leaders have employed in recent years. These moves represent the dynamic nature of the market, where key players build up their positions and meet changing market needs.

In August 2024, Siemens Healthineers agreed to complete the acquisition of the Novartis molecular imaging business for USD 223 million to expand operations for PET radiopharmaceuticals into Europe. This acquisition includes the Advanced Accelerator Applications (AAA), diagnostic manufacturing, and distribution network. Novartis remains with the therapeutic business of AAA. With the said agreement, Siemens cements its position in the European market for PET.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Multimodal Imaging Market Outlook, 2017-2031F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Technology
      • 4.2.1.1. PET/CT Systems
      • 4.2.1.2. SPECT/CT Systems
      • 4.2.1.3. PET/MR Systems
      • 4.2.1.4. OCT/FMT Systems
      • 4.2.1.5. Others
    • 4.2.2. By Application
      • 4.2.2.1. Oncology
      • 4.2.2.2. Cardiology
      • 4.2.2.3. Brain and Neurology
      • 4.2.2.4. Ophthalmology
      • 4.2.2.5. Research
      • 4.2.2.6. Others
    • 4.2.3. By End-user
      • 4.2.3.1. Hospitals
      • 4.2.3.2. Diagnostic Imaging Centers
      • 4.2.3.3. Academic and Research Institutes
      • 4.2.3.4. Others
    • 4.2.4. By Region
      • 4.2.4.1. North America
      • 4.2.4.2. Europe
      • 4.2.4.3. Asia-Pacific
      • 4.2.4.4. South America
      • 4.2.4.5. Middle East and Africa
    • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
  • 4.3. Market Map Analysis, 2023
    • 4.3.1. By Technology
    • 4.3.2. By Application
    • 4.3.3. By End-user
    • 4.3.4. By Region

5. North America Multimodal Imaging Market Outlook, 2017-2031F*

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
    • 5.1.2. By Volume
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Technology
      • 5.2.1.1. PET/CT Systems
      • 5.2.1.2. SPECT/CT Systems
      • 5.2.1.3. PET/MR Systems
      • 5.2.1.4. OCT/FMT Systems
      • 5.2.1.5. Others
    • 5.2.2. By Application
      • 5.2.2.1. Oncology
      • 5.2.2.2. Cardiology
      • 5.2.2.3. Brain and Neurology
      • 5.2.2.4. Ophthalmology
      • 5.2.2.5. Research
      • 5.2.2.6. Others
    • 5.2.3. By End-user
      • 5.2.3.1. Hospitals
      • 5.2.3.2. Diagnostic Imaging Centers
      • 5.2.3.3. Academic and Research Institutes
      • 5.2.3.4. Others
    • 5.2.4. By Country Share
      • 5.2.4.1. United States
      • 5.2.4.2. Canada
      • 5.2.4.3. Mexico
  • 5.3. Country Market Assessment
    • 5.3.1. United States Multimodal Imaging Market Outlook, 2017-2031F*
      • 5.3.1.1. Market Size Analysis & Forecast
        • 5.3.1.1.1. By Value
        • 5.3.1.1.2. By Volume
      • 5.3.1.2. Market Share Analysis & Forecast
        • 5.3.1.2.1. By Technology
          • 5.3.1.2.1.1. PET/CT Systems
          • 5.3.1.2.1.2. SPECT/CT Systems
          • 5.3.1.2.1.3. PET/MR Systems
          • 5.3.1.2.1.4. OCT/FMT Systems
          • 5.3.1.2.1.5. Others
        • 5.3.1.2.2. By Application
          • 5.3.1.2.2.1. Oncology
          • 5.3.1.2.2.2. Cardiology
          • 5.3.1.2.2.3. Brain and Neurology
          • 5.3.1.2.2.4. Ophthalmology
          • 5.3.1.2.2.5. Research
          • 5.3.1.2.2.6. Others
        • 5.3.1.2.3. By End-users
          • 5.3.1.2.3.1. Hospitals
          • 5.3.1.2.3.2. Diagnostic Imaging Centers
          • 5.3.1.2.3.3. Academic and Research Institutes
          • 5.3.1.2.3.4. Others
    • 5.3.2. Canada
    • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Multimodal Imaging Market Outlook, 2017-2031F

  • 6.1. Germany
  • 6.2. France
  • 6.3. Italy
  • 6.4. United Kingdom
  • 6.5. Russia
  • 6.6. Netherlands
  • 6.7. Spain
  • 6.8. Turkey
  • 6.9. Poland

7. Asia-Pacific Multimodal Imaging Market Outlook, 2017-2031F

  • 7.1. India
  • 7.2. China
  • 7.3. Japan
  • 7.4. Australia
  • 7.5. Vietnam
  • 7.6. South Korea
  • 7.7. Indonesia
  • 7.8. Philippines

8. South America Multimodal Imaging Market Outlook, 2017-2031F

  • 8.1. Brazil
  • 8.2. Argentina

9. Middle East and Africa Multimodal Imaging Market Outlook, 2017-2031F

  • 9.1. Saudi Arabia
  • 9.2. UAE
  • 9.3. South Africa

10. Value Chain Analysis

11. Porter's Five Forces Analysis

12. PESTLE Analysis

13. Pricing Analysis

14. Market Dynamics

  • 14.1. Market Drivers
  • 14.2. Market Challenges

15. Market Trends and Developments

16. Regulatory Framework and Innovation

  • 16.1. Regulatory Approvals

17. Patent Landscape

18. Case Studies

19. Competitive Landscape

  • 19.1. Competition Matrix of Top 5 Market Leaders
  • 19.2. SWOT Analysis for Top 5 Players
  • 19.3. Key Players Landscape for Top 10 Market Players
    • 19.3.1. Siemens Healthineers AG
      • 19.3.1.1. Company Details
      • 19.3.1.2. Key Management Personnel
      • 19.3.1.3. Products and Services
      • 19.3.1.4. Financials (As Reported)
      • 19.3.1.5. Key Market Focus and Geographical Presence
      • 19.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
    • 19.3.2. GE HealthCare
    • 19.3.3. Koninklijke Philips N.V.
    • 19.3.4. Canon Medical Systems Corporation
    • 19.3.5. Shanghai United Imaging Healthcare Co., LTD
    • 19.3.6. Neusoft Medical Systems Co., Ltd.
    • 19.3.7. MinFound Medical Systems Co., Ltd
    • 19.3.8. Spectrum Dynamics Medical
    • 19.3.9. Mediso Ltd.
    • 19.3.10. Bruker Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

20. Strategic Recommendations

21. About Us and Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
  • Figure 2. Global Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
  • Figure 3. Global Multimodal Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 4. Global Multimodal Imaging Market Share (%), By Application, 2017-2031F
  • Figure 5. Global Multimodal Imaging Market Share (%), By End-users, 2017-2031F
  • Figure 6. Global Multimodal Imaging Market Share (%), By Region, 2017-2031F
  • Figure 7. North America Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
  • Figure 8. North America Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
  • Figure 9. North America Multimodal Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 10. North America Multimodal Imaging Market Share (%), By Application, 2017-2031F
  • Figure 11. North America Multimodal Imaging Market Share (%), By End-users, 2017-2031F
  • Figure 12. North America Multimodal Imaging Market Share (%), By Country, 2017-2031F
  • Figure 13. United States Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
  • Figure 14. United States Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
  • Figure 15. United States Multimodal Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 16. United States Multimodal Imaging Market Share (%), By Application, 2017-2031F
  • Figure 17. United States Multimodal Imaging Market Share (%), By End-users, 2017-2031F
  • Figure 18. Canada Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
  • Figure 19. Canada Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
  • Figure 20. Canada Multimodal Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 21. Canada Multimodal Imaging Market Share (%), By Application, 2017-2031F
  • Figure 22. Canada Multimodal Imaging Market Share (%), By End-users, 2017-2031F
  • Figure 23. Mexico Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
  • Figure 24. Mexico Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
  • Figure 25. Mexico Multimodal Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 26. Mexico Multimodal Imaging Market Share (%), By Application, 2017-2031F
  • Figure 27. Mexico Multimodal Imaging Market Share (%), By End-users, 2017-2031F
  • Figure 28. Europe Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
  • Figure 29. Europe Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
  • Figure 30. Europe Multimodal Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 31. Europe Multimodal Imaging Market Share (%), By Application, 2017-2031F
  • Figure 32. Europe Multimodal Imaging Market Share (%), By End-users, 2017-2031F
  • Figure 33. Europe Multimodal Imaging Market Share (%), By Country, 2017-2031F
  • Figure 34. Germany Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
  • Figure 35. Germany Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
  • Figure 36. Germany Multimodal Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 37. Germany Multimodal Imaging Market Share (%), By Application, 2017-2031F
  • Figure 38. Germany Multimodal Imaging Market Share (%), By End-users, 2017-2031F
  • Figure 39. France Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
  • Figure 40. France Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
  • Figure 41. France Multimodal Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 42. France Multimodal Imaging Market Share (%), By Application, 2017-2031F
  • Figure 43. France Multimodal Imaging Market Share (%), By End-users, 2017-2031F
  • Figure 44. Italy Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
  • Figure 45. Italy Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
  • Figure 46. Italy Multimodal Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 47. Italy Multimodal Imaging Market Share (%), By Application, 2017-2031F
  • Figure 48. Italy Multimodal Imaging Market Share (%), By End-users, 2017-2031F
  • Figure 49. United Kingdom Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
  • Figure 50. United Kingdom Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
  • Figure 51. United Kingdom Multimodal Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 52. United Kingdom Multimodal Imaging Market Share (%), By Application, 2017-2031F
  • Figure 53. United Kingdom Multimodal Imaging Market Share (%), By End-users, 2017-2031F
  • Figure 54. Russia Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
  • Figure 55. Russia Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
  • Figure 56. Russia Multimodal Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 57. Russia Multimodal Imaging Market Share (%), By Application, 2017-2031F
  • Figure 58. Russia Multimodal Imaging Market Share (%), By End-users, 2017-2031F
  • Figure 59. Netherlands Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
  • Figure 60. Netherlands Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
  • Figure 61. Netherlands Multimodal Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 62. Netherlands Multimodal Imaging Market Share (%), By Application, 2017-2031F
  • Figure 63. Netherlands Multimodal Imaging Market Share (%), By End-users, 2017-2031F
  • Figure 64. Spain Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
  • Figure 65. Spain Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
  • Figure 66. Spain Multimodal Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 67. Spain Multimodal Imaging Market Share (%), By Application, 2017-2031F
  • Figure 68. Spain Multimodal Imaging Market Share (%), By End-users, 2017-2031F
  • Figure 69. Turkey Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
  • Figure 70. Turkey Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
  • Figure 71. Turkey Multimodal Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 72. Turkey Multimodal Imaging Market Share (%), By Application, 2017-2031F
  • Figure 73. Turkey Multimodal Imaging Market Share (%), By End-users, 2017-2031F
  • Figure 74. Poland Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
  • Figure 75. Poland Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
  • Figure 76. Poland Multimodal Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 77. Poland Multimodal Imaging Market Share (%), By Application, 2017-2031F
  • Figure 78. Poland Multimodal Imaging Market Share (%), By End-users, 2017-2031F
  • Figure 79. South America Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
  • Figure 80. South America Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
  • Figure 81. South America Multimodal Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 82. South America Multimodal Imaging Market Share (%), By Application, 2017-2031F
  • Figure 83. South America Multimodal Imaging Market Share (%), By End-users, 2017-2031F
  • Figure 84. South America Multimodal Imaging Market Share (%), By Country, 2017-2031F
  • Figure 85. Brazil Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
  • Figure 86. Brazil Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
  • Figure 87. Brazil Multimodal Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 88. Brazil Multimodal Imaging Market Share (%), By Application, 2017-2031F
  • Figure 89. Brazil Multimodal Imaging Market Share (%), By End-users, 2017-2031F
  • Figure 90. Argentina Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
  • Figure 91. Argentina Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
  • Figure 92. Argentina Multimodal Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 93. Argentina Multimodal Imaging Market Share (%), By Application, 2017-2031F
  • Figure 94. Argentina Multimodal Imaging Market Share (%), By End-users, 2017-2031F
  • Figure 95. Asia-Pacific Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
  • Figure 96. Asia-Pacific Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
  • Figure 97. Asia-Pacific Multimodal Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 98. Asia-Pacific Multimodal Imaging Market Share (%), By Application, 2017-2031F
  • Figure 99. Asia-Pacific Multimodal Imaging Market Share (%), By End-users, 2017-2031F
  • Figure 100. Asia-Pacific Multimodal Imaging Market Share (%), By Country, 2017-2031F
  • Figure 101. India Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
  • Figure 102. India Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
  • Figure 103. India Multimodal Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 104. India Multimodal Imaging Market Share (%), By Application, 2017-2031F
  • Figure 105. India Multimodal Imaging Market Share (%), By End-users, 2017-2031F
  • Figure 106. China Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
  • Figure 107. China Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
  • Figure 108. China Multimodal Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 109. China Multimodal Imaging Market Share (%), By Application, 2017-2031F
  • Figure 110. China Multimodal Imaging Market Share (%), By End-users, 2017-2031F
  • Figure 111. Japan Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
  • Figure 112. Japan Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
  • Figure 113. Japan Multimodal Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 114. Japan Multimodal Imaging Market Share (%), By Application, 2017-2031F
  • Figure 115. Japan Multimodal Imaging Market Share (%), By End-users, 2017-2031F
  • Figure 116. Australia Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
  • Figure 117. Australia Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
  • Figure 118. Australia Multimodal Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 119. Australia Multimodal Imaging Market Share (%), By Application, 2017-2031F
  • Figure 120. Australia Multimodal Imaging Market Share (%), By End-users, 2017-2031F
  • Figure 121. Vietnam Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
  • Figure 122. Vietnam Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
  • Figure 123. Vietnam Multimodal Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 124. Vietnam Multimodal Imaging Market Share (%), By Application, 2017-2031F
  • Figure 125. Vietnam Multimodal Imaging Market Share (%), By End-users, 2017-2031F
  • Figure 126. South Korea Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
  • Figure 127. South Korea Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
  • Figure 128. South Korea Multimodal Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 129. South Korea Multimodal Imaging Market Share (%), By Application, 2017-2031F
  • Figure 130. South Korea Multimodal Imaging Market Share (%), By End-users, 2017-2031F
  • Figure 131. Indonesia Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
  • Figure 132. Indonesia Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
  • Figure 133. Indonesia Multimodal Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 134. Indonesia Multimodal Imaging Market Share (%), By Application, 2017-2031F
  • Figure 135. Indonesia Multimodal Imaging Market Share (%), By End-users, 2017-2031F
  • Figure 136. Philippines Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
  • Figure 137. Philippines Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
  • Figure 138. Philippines Multimodal Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 139. Philippines Multimodal Imaging Market Share (%), By Application, 2017-2031F
  • Figure 140. Philippines Multimodal Imaging Market Share (%), By End-users, 2017-2031F
  • Figure 141. Middle East & Africa Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
  • Figure 142. Middle East & Africa Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
  • Figure 143. Middle East & Africa Multimodal Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 144. Middle East & Africa Multimodal Imaging Market Share (%), By Application, 2017-2031F
  • Figure 145. Middle East & Africa Multimodal Imaging Market Share (%), By End-users, 2017-2031F
  • Figure 146. Middle East & Africa Multimodal Imaging Market Share (%), By Country, 2017-2031F
  • Figure 147. Saudi Arabia Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
  • Figure 148. Saudi Arabia Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
  • Figure 149. Saudi Arabia Multimodal Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 150. Saudi Arabia Multimodal Imaging Market Share (%), By Application, 2017-2031F
  • Figure 151. Saudi Arabia Multimodal Imaging Market Share (%), By End-users, 2017-2031F
  • Figure 152. UAE Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
  • Figure 153. UAE Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
  • Figure 154. UAE Multimodal Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 155. UAE Multimodal Imaging Market Share (%), By Application, 2017-2031F
  • Figure 156. UAE Multimodal Imaging Market Share (%), By End-users, 2017-2031F
  • Figure 157. South Africa Multimodal Imaging Market, By Value, in USD Billion, 2017-2031F
  • Figure 158. South Africa Multimodal Imaging Market, By Volume, in Million Units, 2017-2031F
  • Figure 159. South Africa Multimodal Imaging Market Share (%), By Technology, 2017-2031F
  • Figure 160. South Africa Multimodal Imaging Market Share (%), By Application, 2017-2031F
  • Figure 161. South Africa Multimodal Imaging Market Share (%), By End-users, 2017-2031F
  • Figure 162. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 163. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 164. By End-users Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 165. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023